Inducible tissue constructs and uses thereof
US-2024287463-A1 · Aug 29, 2024 · US
US9499824B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9499824-B2 |
| Application number | US-201514920598-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2015 |
| Priority date | Feb 22, 2008 |
| Publication date | Nov 22, 2016 |
| Grant date | Nov 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods of modulating transcription or transcription or transcriptional control using isolated and/or purified polypeptides and nucleic acid sequences from Alicyclobacillus acidocaldarius.
Opening claim text (preview).
What is claimed is: 1. An expression vector comprising a nucleic acid encoding a polypeptide having at least 95% sequence identity to SEQ ID NO: 1497 and wherein the polypeptide is a central glycolytic genes regulator. 2. The expression vector of claim 1 , wherein the polypeptide is a central glycolytic genes regulator at a temperature at or above 50 degrees Celsius. 3. The expression vector isolated of claim 1 , wherein the polypeptide has 100% identity to SEQ ID NO: 1497. 4. The expression vector isolated of claim 1 , wherein the nucleic acid has at least 95% identity to SEQ ID NO: 1498. 5. The expression vector isolated of claim 1 , wherein the nucleic acid has 100% identity to SEQ ID NO: 1498. 6. A cell comprising the expression vector of claim 1 . 7. A method of modulating transcription or transcriptional control at temperatures at or above 25 degrees Celsius, the method comprising providing to a transcriptional system the expression vector of claim 1 . 8. The method according to claim 7 , wherein providing to a transcriptional system the expression vector of claim 1 occurs at a temperature at or above 50 degrees Celsius.
Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline · CPC title
from bacteria · CPC title
Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.